CHRISTIE PHILLIPS-FEARIS: Open Payments
NPI 1629579578 · RINCON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 28 payments from 15 companies in 2025. Trend: 2023 $717 · 2024 $669 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| PFIZER INC. | 3 | $58 |
| Amgen Inc. | 4 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Novo Nordisk Inc | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Boston Scientific Corporation | 1 | $25 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Medtronic, Inc. | 1 | $20 |
Products named: JARDIANCE, OTEZLA, Kerendia, FARXIGA, ELIQUIS, GEMTESA, PREVNAR 20, General - Pain Management.
Industry payments across GA — which companies pay providers there.
